- Investing.com
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular and cerebrovascular, psychotropic, hepatobiliary and anti-tumor categories. It also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, the company exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.
Metrics to compare | 000739 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000739PeersSector | |
---|---|---|---|---|
P/E Ratio | 19.4x | 26.3x | −0.7x | |
PEG Ratio | −2.07 | 0.48 | 0.00 | |
Price/Book | 2.8x | 2.9x | 2.6x | |
Price / LTM Sales | 1.7x | 5.0x | 3.4x | |
Upside (Analyst Target) | 16.0% | 24.3% | 35.5% | |
Fair Value Upside | Unlock | 9.4% | 3.3% | Unlock |